Death of p53-defective cells triggered by forced mitotic entry in the presence of DNA damage is not uniquely dependent on Caspase-2 or the PIDDosome

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Manzl, C ^a,b   Fava, L L ^a   Krumschnabel, G ^a   Peintner, L ^a   Tanzer, M C ^a,c   Soratroi, C ^a   Bock, F J ^a,d   Schuler, F ^a   Luef, B ^a   Geley, S ^a   Villunger, A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Caspase 2; Chk1; DNA damage; p53; PIDDosome

Indexed keywords

CASPASE 2; CASPASE 3; CHECKPOINT KINASE 1; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CANCER CELL; CELL DEATH; CELL STIMULATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GAMMA IRRADIATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOSIS; MOUSE; NONHUMAN; ONCOGENE C MYC; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CASPASE 2; CELL CYCLE; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DNA DAMAGE; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MITOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84891795755     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.470     Document Type: Article

References (34)

1. Reinhardt HC, Yaffe MB. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 2009; 21: 245-255
2. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T et al. Aberrant cell cycle checkpoint function and early embryonic death in Chk1-/-mice. Genes Dev 2000; 14: 1439-1447
3. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K et al. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev 2000; 14: 1448-1459
4. Greenow KR, Clarke AR, Jones RH. Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene 2009; 28: 1443-1453
5. Zaugg K, Su YW, Reilly PT, Moolani Y, Cheung CC, Hakem R et al. Cross-Talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci USA 2007; 104: 3805-3810
6. Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12: 385-392
7. Janssen A, Medema RH. Mitosis as an anti-cancer target. Oncogene 2011; 30: 2799-2809
8. Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008; 133: 864-877
9. Bock FJ, Peintner L, Tanzer M, Manzl C, Villunger A. P53-induced protein with a death domain (PIDD): Master of puppets? Oncogene 2012; 31: 4733-4739
10. Ando K, Kernan JL, Liu PH, Sanda T, Logette E, Tschopp J et al. PIDD Death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling. Mol Cell 2012; 47: 681-693
11. Ma CX, Janetka JW, Piwnica-Worms H. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med 2011; 17: 88-96
12. Aarts M, Linardopoulos S, Turner NC. Tumour selective targeting of cell cycle kinases for cancer treatment. Curr Opin Pharmacol 2013; 13: 529-535
13. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602
14. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994; 79: 329-339
15. Sohn D, Budach W, Janicke RU. Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell Death Differ 2011; 18: 1664-1674
16. Ho LH, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S. A tumor suppressor function for caspase-2. Proc Natl Acad Sci USA 2009; 106: 5336-5341
17. Tischner D, Manzl C, Soratroi C, Villunger A, Krumschnabel G. Necrosis-like death can engage multiple pro-Apoptotic Bcl-2 protein family members. Apoptosis 2012; 17: 1197-1209
18. Toledo LI, Murga M, Fernandez-Capetillo O. Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs. Mol Oncol 2011; 5: 368-373
19. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993; 268: 9194-9197
20. Kohn EA, Yoo CJ, Eastman A. The protein kinase C inhibitor Go6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints. Cancer Res 2003; 63: 31-35
21. Reyland ME. Protein kinase C isoforms: Multi-functional regulators of cell life and death. Front Biosci 2009; 14: 2386-2399
22. Bluwstein A, Kumar N, Leger K, Traenkle J, Oostrum J, Rehrauer H et al. PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts. Cell Death Dis 2013; 4: E498
23. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. p53-deficient cells rely on ATM-And ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007; 11: 175-189
24. Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X et al. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell 2010; 40: 34-49
25. Zenvirt S, Kravchenko-Balasha N, Levitzki A. Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents. Oncogene 2010; 29: 6149-6159
26. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 2006; 25: 5683-5692
27. Kim IR, Murakami K, Chen NJ, Saibil SD, Matysiak-Zablocki E, Elford AR et al. DNA damage-And stress-induced apoptosis occurs independently of PIDD. Apoptosis 2009; 14: 1039-1049
28. Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F et al. Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol 2009; 185: 291-303
29. Bock FJ, Krumschnabel G, Manzl C, Peintner L, Tanzer MC, Hermann-Kleiter N et al. Loss of PIDD limits NF-kappaB activation and cytokine production but not cell survival or transformation after DNA damage. Cell Death Differ 2013; 20: 546-557
30. O'Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002; 9: 832-841
31. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1-7
32. Kaplan HS, Brown MB. A quantitative dose-response study of lymphoid-Tumor development in irradiated C57 black mice. J Natl Cancer Inst 1952; 13: 185-208
33. Labi V, Erlacher M, Kiessling S, Manzl C, Frenzel A, O'Reilly L et al. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med 2008; 205: 641-655
34. Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S et al. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2008; 22: 370-377